Nov 16, 2020 / 06:30PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Welcome, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at Barclays. It's my great pleasure to introduce our next presenting company MeiraGTx. With me on the Zoom meeting is Zandy Forbes, President and Chief Executive Officer; and also Elizabeth Anderson, VP of Investor Relations.
With that, I hand over to you, Zandy.
Alexandria Forbes - MeiraGTx Holdings plc - CEO, President & Director
Thank you, Gena, and thank you for Barclays inviting us to speak and chat with you at this conference. I'm going to give a quick overview of the company. And then I think we will touch on a number of aspects I'm going to mention in our conversation. So if we could go to the first slide, please, Elizabeth.
So Meira is a gene therapy company that was really formed to address or innovate in this new space of gene therapy to create pharmaceuticals that could cost effectively treat a broad range of serious disorders. That means that from the perspective of Meira, we're really
MeiraGTx Holdings PLC at Barclays Virtual Gene Editing & Gene Therapy Summit Transcript
Nov 17, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers